Advertisement
Screener

Exelixis Inc (EXEL) Investing Cash Flow

3.5 / 5 stars · 77/111 Roast Me

Exelixis Inc Investing Cash Flow

Exelixis Inc (EXEL) reported Investing Cash Flow of $40.36 million for the 6-month period ending 2026-07-03, per its 10-Q filed 2026-08-05.

Financial Statements › Cash Flow › Investing Activities

us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-05

  • Exelixis Inc net cash provided by (used in) investing activities for the quarter ending 2026-07-03 was $91.43M, a 63.14% decline year-over-year.
  • Exelixis Inc net cash provided by (used in) investing activities for the quarter ending 2026-04-03 was -$51.07M, a 202.62% decline year-over-year.
  • Exelixis Inc net cash provided by (used in) investing activities for the quarter ending 2026-01-02 was $27.24M.
  • Exelixis Inc net cash provided by (used in) investing activities for the quarter ending 2025-10-03 was $25.41M.
  • Exelixis Inc net cash provided by (used in) investing activities for fiscal 2026 was $350.44M.
  • Exelixis Inc net cash provided by (used in) investing activities for fiscal 2025 was -$116.78M.
  • Exelixis Inc net cash provided by (used in) investing activities for fiscal 2023 was -$26.95M.
  • Exelixis Inc net cash provided by (used in) investing activities for fiscal 2022 was -$524.41M.
Period endNet Cash Provided by (Used in) Investing Activities 3 monthNet Cash Provided by (Used in) Investing Activities 6 monthNet Cash Provided by (Used in) Investing Activities 9 monthNet Cash Provided by (Used in) Investing Activities 12 monthNet Cash Provided by (Used in) Investing Activities 12 month as first filed
2026-07-03$91.43M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05
$40.36M
10-Q · filed 2026-08-05
$67.60M
derived: sum of 3 quarters · filed 2026-08-05
$93.01M
derived: sum of 4 quarters · filed 2026-08-05
2026-04-03-$51.07M
10-Q · filed 2026-05-05
-$23.83M
derived: sum of 2 quarters · filed 2026-05-05
$1.58M
derived: sum of 3 quarters · filed 2026-05-05
$249.61M
derived: sum of 4 quarters · filed 2026-08-05
2026-01-02$27.24M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10
$52.65M
derived: sum of 2 quarters · filed 2026-02-10
$300.68M
derived: sum of 3 quarters · filed 2026-08-05
$350.44M
10-K · filed 2026-02-10
2025-10-03$25.41M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04
$273.44M
derived: sum of 2 quarters · filed 2026-08-05
$323.20M
10-Q · filed 2025-11-04
$230.00M
derived: sum of 4 quarters · filed 2026-08-05
2025-07-04$248.03M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05
$297.80M
10-Q · filed 2026-08-05
$204.59M
derived: sum of 3 quarters · filed 2026-08-05
-$12.55M
derived: sum of 4 quarters · filed 2026-08-05
2025-04-04$49.76M
10-Q · filed 2026-05-05
-$43.44M
derived: sum of 2 quarters · filed 2026-05-05
-$260.58M
derived: sum of 3 quarters · filed 2026-05-05
-$178.81M
derived: sum of 4 quarters · filed 2026-05-05
2025-01-03-$93.20M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10
-$310.35M
derived: sum of 2 quarters · filed 2026-02-10
-$228.58M
derived: sum of 3 quarters · filed 2026-02-10
-$116.78M
10-K · filed 2026-02-10
2024-09-27-$217.15M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04
-$135.38M
derived: sum of 2 quarters · filed 2025-11-04
-$23.58M
10-Q · filed 2025-11-04
$38.16M
derived: sum of 4 quarters · filed 2026-02-10
2024-06-28$81.77M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-28
$193.56M
10-Q · filed 2025-07-28
$255.30M
derived: sum of 3 quarters · filed 2026-02-10
$289.99M
derived: sum of 4 quarters · filed 2026-02-10
2024-03-29$111.79M
10-Q · filed 2025-05-13
$173.53M
derived: sum of 2 quarters · filed 2026-02-10
$208.22M
derived: sum of 3 quarters · filed 2026-02-10
$134.43M
derived: sum of 4 quarters · filed 2026-02-10
2023-12-29$61.74M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10
$96.42M
derived: sum of 2 quarters · filed 2026-02-10
$22.64M
derived: sum of 3 quarters · filed 2026-02-10
-$26.95M
10-K · filed 2026-02-10
2023-09-29$34.69M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29
-$39.10M
derived: sum of 2 quarters · filed 2024-10-29
-$88.69M
10-Q · filed 2024-10-29
-$334.47M
derived: sum of 4 quarters · filed 2025-02-11
2023-06-30-$73.78M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06
-$123.38M
10-Q · filed 2024-08-06
-$369.16M
derived: sum of 3 quarters · filed 2025-02-11
-$438.11M
derived: sum of 4 quarters · filed 2025-02-11
2023-03-31-$49.59M
10-Q · filed 2024-04-30
-$295.37M
derived: sum of 2 quarters · filed 2025-02-11
-$364.32M
derived: sum of 3 quarters · filed 2025-02-11
-$499.47M
derived: sum of 4 quarters · filed 2025-02-11
2022-12-30-$245.78M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-11
-$314.73M
derived: sum of 2 quarters · filed 2025-02-11
-$449.88M
derived: sum of 3 quarters · filed 2025-02-11
-$524.41M
10-K · filed 2025-02-11
2022-09-30-$68.95M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01
-$204.09M
derived: sum of 2 quarters · filed 2023-11-01
-$278.63M
10-Q · filed 2023-11-01
-$291.69M
derived: sum of 4 quarters · filed 2024-02-06
2022-07-01-$135.14M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01
-$209.68M
10-Q · filed 2023-08-01
-$222.74M
derived: sum of 3 quarters · filed 2024-02-06
-$243.97M
derived: sum of 4 quarters · filed 2024-02-06
2022-04-01-$74.54M
10-Q · filed 2023-05-09
-$87.59M
derived: sum of 2 quarters · filed 2024-02-06
-$108.83M
derived: sum of 3 quarters · filed 2024-02-06
-$179.68M
derived: sum of 4 quarters · filed 2024-02-06
2021-12-31-$13.05M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-06
-$34.29M
derived: sum of 2 quarters · filed 2024-02-06
-$105.14M
derived: sum of 3 quarters · filed 2024-02-06
-$42.88M
10-K · filed 2024-02-06
2021-10-01-$21.24M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01
-$92.08M
derived: sum of 2 quarters · filed 2022-11-01
-$29.83M
10-Q · filed 2022-11-01
-$59.34M
derived: sum of 4 quarters · filed 2023-02-07
2021-07-02-$70.84M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09
-$8.59M
10-Q · filed 2022-08-09
-$38.10M
derived: sum of 3 quarters · filed 2023-02-07
-$245.70M
derived: sum of 4 quarters · filed 2023-02-07
2021-04-02$62.26M
10-Q · filed 2022-05-10
$32.75M
derived: sum of 2 quarters · filed 2023-02-07
-$174.85M
derived: sum of 3 quarters · filed 2023-02-07
-$101.58M
derived: sum of 4 quarters · filed 2023-02-07
2021-01-01-$29.51M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-07
-$237.11M
derived: sum of 2 quarters · filed 2023-02-07
-$163.84M
derived: sum of 3 quarters · filed 2023-02-07
-$131.22M
10-K · filed 2023-02-07
2020-10-02-$207.60M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02
-$134.33M
derived: sum of 2 quarters · filed 2021-11-02
-$101.71M
10-Q · filed 2021-11-02
-$231.91M
derived: sum of 4 quarters · filed 2022-02-18
2020-07-03$73.27M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05
$105.89M
10-Q · filed 2021-08-05
-$24.31M
derived: sum of 3 quarters · filed 2022-02-18
-$230.77M
derived: sum of 4 quarters · filed 2022-02-18
2020-04-03$32.62M
10-Q · filed 2021-05-06
-$97.58M
derived: sum of 2 quarters · filed 2022-02-18
-$304.04M
derived: sum of 3 quarters · filed 2022-02-18
-$446.97M
derived: sum of 4 quarters · filed 2022-02-18
2020-01-03-$130.20M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-18
-$336.66M
derived: sum of 2 quarters · filed 2022-02-18
-$479.59M
derived: sum of 3 quarters · filed 2022-02-18
-$587.25M
10-K · filed 2022-02-18
2019-09-27-$206.46M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05
-$349.39M
derived: sum of 2 quarters · filed 2020-11-05
-$457.05M
10-Q · filed 2020-11-05
-$599.85M
derived: sum of 4 quarters · filed 2020-11-05
2019-06-28-$142.93M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06
-$250.59M
10-Q · filed 2020-08-06
-$393.38M
derived: sum of 3 quarters · filed 2020-08-06
-$456.64M
derived: sum of 4 quarters · filed 2020-08-06
2019-03-29-$107.66M
10-Q · filed 2020-05-05
-$250.46M
derived: sum of 2 quarters · filed 2020-05-05
-$313.71M
derived: sum of 3 quarters · filed 2020-05-05
-$379.97M
derived: sum of 4 quarters · filed 2020-05-05
2018-12-28-$142.80M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25
-$206.05M
derived: sum of 2 quarters · filed 2020-02-25
-$272.32M
derived: sum of 3 quarters · filed 2020-02-25
-$297.85M
10-K · filed 2021-02-11
2018-09-28-$63.25M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30
-$129.52M
derived: sum of 2 quarters · filed 2019-10-30
-$155.05M
10-Q · filed 2019-10-30
-$173.38M
derived: sum of 4 quarters · filed 2020-02-25
2018-06-29-$66.27M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31
-$91.80M
10-Q · filed 2019-07-31
-$110.13M
derived: sum of 3 quarters · filed 2020-02-25
-$136.72M
derived: sum of 4 quarters · filed 2020-02-25
2018-03-30-$25.53M
10-Q · filed 2019-05-01
-$43.87M
derived: sum of 2 quarters · filed 2020-02-25
-$70.46M
derived: sum of 3 quarters · filed 2020-02-25
2017-12-29-$18.33M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25
-$44.92M
derived: sum of 2 quarters · filed 2020-02-25
$36.80M
10-K · filed 2020-02-25
$35.80M
10-K · filed 2018-02-26
2017-09-30-$26.59M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01
$54.63M
10-Q · filed 2017-11-01
2017-09-29-$26.59M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01
$20.13M
derived: sum of 2 quarters · filed 2018-11-01
$55.13M
10-Q · filed 2018-11-01
-$5.78M
derived: sum of 4 quarters · filed 2018-11-01
2017-06-30$46.72M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02
$81.22M
10-Q · filed 2017-08-02
$20.81M
derived: sum of 3 quarters · filed 2018-05-02
$8.68M
derived: sum of 4 quarters · filed 2018-05-02
2017-03-31$34.50M
10-Q · filed 2017-05-01
-$25.91M
derived: sum of 2 quarters · filed 2018-05-02
-$38.03M
derived: sum of 3 quarters · filed 2018-05-02
-$161.86M
derived: sum of 4 quarters · filed 2018-05-02
2016-12-31-$60.41M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27
-$72.54M
derived: sum of 2 quarters · filed 2017-11-01
-$196.36M
derived: sum of 3 quarters · filed 2017-11-01
-$216.05M
10-K · filed 2017-02-27
2016-12-30-$214.55M
10-K · filed 2019-02-22
-$216.05M
10-K · filed 2018-02-26
2016-09-30-$12.13M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01
-$135.95M
derived: sum of 2 quarters · filed 2017-11-01
-$155.64M
10-Q · filed 2017-11-01
-$131.63M
derived: sum of 4 quarters · filed 2017-11-01
2016-06-30-$123.83M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02
-$143.51M
10-Q · filed 2017-08-02
-$119.50M
derived: sum of 3 quarters · filed 2017-08-02
-$151.01M
derived: sum of 4 quarters · filed 2017-08-02
2016-03-31-$19.68M
10-Q · filed 2017-05-01
$4.32M
derived: sum of 2 quarters · filed 2017-05-01
-$27.19M
derived: sum of 3 quarters · filed 2017-05-01
-$19.50M
derived: sum of 4 quarters · filed 2017-05-01
2016-01-01$50.08M
10-K · filed 2018-02-26
2015-12-31$24.01M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27
-$7.50M
derived: sum of 2 quarters · filed 2017-02-27
$182.00K
derived: sum of 3 quarters · filed 2017-02-27
$50.08M
10-K · filed 2017-02-27
2015-09-30-$31.51M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03
-$23.83M
derived: sum of 2 quarters · filed 2016-11-03
$26.07M
10-Q · filed 2016-11-03
$56.24M
derived: sum of 4 quarters · filed 2017-02-27
2015-06-30$7.68M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03
$57.58M
10-Q · filed 2016-08-03
$87.76M
derived: sum of 3 quarters · filed 2017-02-27
$98.86M
derived: sum of 4 quarters · filed 2017-02-27
2015-03-31$49.90M
10-Q · filed 2016-05-04
$80.07M
derived: sum of 2 quarters · filed 2017-02-27
$91.18M
derived: sum of 3 quarters · filed 2017-02-27
$135.87M
derived: sum of 4 quarters · filed 2017-02-27
2014-12-31$30.18M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27
$41.28M
derived: sum of 2 quarters · filed 2017-02-27
$85.97M
derived: sum of 3 quarters · filed 2017-02-27
$146.33M
10-K · filed 2017-02-27
2014-09-30$11.11M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10
$55.79M
derived: sum of 2 quarters · filed 2015-11-10
$116.15M
10-Q · filed 2015-11-10
$175.66M
derived: sum of 4 quarters · filed 2016-02-29
2014-06-30$44.69M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-11
$105.05M
10-Q · filed 2015-08-11
$164.55M
derived: sum of 3 quarters · filed 2016-02-29
$182.58M
derived: sum of 4 quarters · filed 2016-02-29
2014-03-31$60.36M
10-Q · filed 2015-04-30
$119.86M
derived: sum of 2 quarters · filed 2016-02-29
$137.89M
derived: sum of 3 quarters · filed 2016-02-29
$138.36M
derived: sum of 4 quarters · filed 2016-02-29
2013-12-31$59.51M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29
$77.53M
derived: sum of 2 quarters · filed 2016-02-29
$78.00M
derived: sum of 3 quarters · filed 2016-02-29
$144.35M
10-K · filed 2016-02-29
2013-09-30$18.03M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-04
$18.49M
derived: sum of 2 quarters · filed 2014-11-04
$84.85M
10-Q · filed 2014-11-04
-$14.78M
derived: sum of 4 quarters · filed 2015-03-02
2013-06-30$467.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31
$66.82M
10-Q · filed 2014-07-31
-$32.81M
derived: sum of 3 quarters · filed 2015-03-02
-$174.01M
derived: sum of 4 quarters · filed 2015-03-02
2013-03-31$66.35M
10-Q · filed 2014-05-01
-$33.28M
derived: sum of 2 quarters · filed 2015-03-02
-$174.48M
derived: sum of 3 quarters · filed 2015-03-02
-$140.84M
derived: sum of 4 quarters · filed 2015-03-02
2012-12-31-$99.63M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02
-$240.84M
derived: sum of 2 quarters · filed 2015-03-02
-$207.19M
derived: sum of 3 quarters · filed 2015-03-02
-$259.47M
10-K · filed 2015-03-02
2012-09-30-$141.21M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-30
-$107.56M
derived: sum of 2 quarters · filed 2013-10-30
-$159.84M
10-Q · filed 2013-10-30
-$122.47M
derived: sum of 4 quarters · filed 2014-02-20
2012-06-30$33.64M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06
-$18.64M
10-Q · filed 2013-08-06
$18.74M
derived: sum of 3 quarters · filed 2014-02-20
$51.30M
derived: sum of 4 quarters · filed 2014-02-20
2012-03-31-$52.28M
10-Q · filed 2013-05-07
-$14.90M
derived: sum of 2 quarters · filed 2014-02-20
$17.66M
derived: sum of 3 quarters · filed 2014-02-20
-$72.24M
derived: sum of 4 quarters · filed 2014-02-20
2011-12-31$37.38M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-20
$69.93M
derived: sum of 2 quarters · filed 2014-02-20
-$19.96M
derived: sum of 3 quarters · filed 2014-02-20
-$51.46M
10-K · filed 2014-02-20
2011-09-30$32.56M
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07
-$57.34M
derived: sum of 2 quarters · filed 2012-11-07
-$88.84M
10-Q · filed 2012-11-07
-$82.44M
derived: sum of 4 quarters · filed 2013-02-21
2011-06-30-$89.89M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-02
-$121.40M
10-Q · filed 2012-08-02
-$115.00M
derived: sum of 3 quarters · filed 2013-02-21
-$130.19M
derived: sum of 4 quarters · filed 2013-02-21
2011-03-31-$31.50M
10-Q · filed 2012-05-03
-$25.11M
derived: sum of 2 quarters · filed 2013-02-21
-$40.30M
derived: sum of 3 quarters · filed 2013-02-21
2010-12-31$6.39M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-21
-$8.80M
derived: sum of 2 quarters · filed 2013-02-21
-$19.57M
10-K · filed 2013-02-21
2010-09-30-$15.19M
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-27
-$25.96M
10-Q · filed 2011-10-27
2010-06-30-$10.77M
10-Q · filed 2011-08-04
2009-12-31-$112.32M
10-K · filed 2012-02-22

Similar stocks

Stock NameCountryMarket CapPE Ratio
NEUROCRINE BIOSCIENCES INC (NBIX)United States$14.131B24.25
HALOZYME THERAPEUTICS, INC. (HALO)United States$13.083B21.59
Twist Bioscience Corp (TWST)United States$11.540B-47.21
BIO-TECHNE Corp (TECH)United States$11.379B74.68
REPLIGEN CORP (RGEN)United States$10.755B185.31
Krystal Biotech, Inc. (KRYS)United States$10.210B45.56
Kymera Therapeutics, Inc. (KYMR)United States$9.631B-31.69
ImmunityBio, Inc. (IBRX)United States$9.157B-9.29
Vaxcyte, Inc. (PCVX)United States$8.466B-7.91
Immunovant, Inc. (IMVT)United States$7.028B-14.78